Global Transdermal Drug Patches Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Transdermal Drug Patches market size was valued at US$ 7040 million in 2024 and is forecast to a readjusted size of USD 7974 million by 2031 with a CAGR of 1.8% during review period.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.

This report is a detailed and comprehensive analysis for global Transdermal Drug Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Transdermal Drug Patches market size and forecasts, in consumption value ($ Million), sales quantity (M Pieces), and average selling prices (USD/Piece), 2020-2031

Global Transdermal Drug Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pieces), and average selling prices (USD/Piece), 2020-2031

Global Transdermal Drug Patches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pieces), and average selling prices (USD/Piece), 2020-2031

Global Transdermal Drug Patches market shares of main players, shipments in revenue ($ Million), sales quantity (M Pieces), and ASP (USD/Piece), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Transdermal Drug Patches

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Transdermal Drug Patches market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem, Nitto Denko, Grünenthal, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Transdermal Drug Patches market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Market segment by Application
Rx Channel
OTC Channel

Major players covered
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales quantity, revenue, and global market share of Transdermal Drug Patches from 2020 to 2025.

Chapter 3, the Transdermal Drug Patches competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Transdermal Drug Patches market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Drug Patches.

Chapter 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion.